Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 27, 2012
Superior vena cava syndrome in childrenVineeta Gupta, Srikanth R Ambati, P Pant, et al.
American Journal of Hematology|May 4, 2013
Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year studySrikanth R Ambati, Rachel E Randolph, Kevin Mennitt, et al.
Pediatric Blood & Cancer|July 19, 2016
A single-center experience with undifferentiated embryonal sarcoma of the liverMelissa D Mathias, Srikanth R Ambati, Alexander J Chou, et al.
Theranostics|June 10, 2016
Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered ModelAranzazu Villasante, Alessandro Marturano-Kruik, Srikanth R Ambati, et al.
Oncotarget|June 2, 2016
BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma modelsSrikanth R Ambati, Jae-Hung Shieh, Benet Pera, et al.
British Journal of Haematology|July 27, 2022
Complete responses to odronextamab in two patients with diffuse large B-cell lymphoma refractory to chimeric antigen receptor T-cell therapyMatt Weinstock, Pavania Elavalakanar, Susan Bright, et al.
Molecular Oncology|January 7, 2014
Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcomaSrikanth R Ambati, Eloisi Caldas Lopes, Kohji Kosugi, et al.
Clinical and Translational Science|January 8, 2022
Translational findings for odronextamab: From preclinical research to a first-in-human study in patients with CD20+ B-cell malignanciesMin Zhu, Kara Olson, Jessica R Kirshner, et al.
JCO Precision Oncology|April 10, 2018
Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with EWSR1 fusion-positive sarcomasNeerav N Shukla, Juber A Patel, Heather Magnan, et al.
Journal for Immunotherapy of Cancer|March 22, 2024
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphomaJurriaan Brouwer-Visser, Nathalie Fiaschi, Raquel P Deering, et al.
Pageof 2